semaglutide nda Semaglutide: First Global Approval | Drugs FDA Warns on Certain Forms

Staying at a lower dose longer is a legitimate clinical strategy and often produces better tolerability with only modest reduction in weight loss speed

/ Look through the window of your pen to ensure the liquid is clear and colorless

Temperature fluctuations, light exposure, and physical agitation can cause the peptide chains to break down or aggregate, potentially reducing the medication's effectiveness

Bupropion/naltrexone (Contrave) and phentermine/topiramate (Qsymia) are other prescription medications approved for weight management that may be considered, depending on the patients overall health profile

Cloudiness indicates protein aggregation, meaning semaglutide molecules have clumped together into larger particles that scatter light